Firefly Neuroscience (AIFF) Free Cash Flow (2010 - 2026)

Firefly Neuroscience has reported Free Cash Flow for 17 years, with the latest figure at -$1.8 million in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 25.4% year-over-year to -$1.8 million in Q2 2026; TTM through Jun 2026 was -$7.2 million, a 41.97% increase from a year earlier, with the FY2025 full-year figure at -$8.3 million, down 32.03% from the prior year.
• Free Cash Flow was -$1.8 million for Q2 2026 at Firefly Neuroscience, up from -$2.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $491536.0 in Q3 2023, with the low at -$5.0 million in Q3 2024.
• Average Free Cash Flow over 5 years is -$1.8 million, with a median of -$1.8 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 1337.98% in 2022, then surged 151.92% in 2023.
• Over 5 years, Free Cash Flow stood at -$2.9 million in 2022, then jumped by 82.33% to -$510000.0 in 2023, then tumbled by 881.37% to -$5.0 million in 2024, then jumped by 63.48% to -$1.8 million in 2025, then advanced by 1.97% to -$1.8 million in 2026.
• The last three Free Cash Flow figures came in at -$1.8 million (Q2 2026), -$2.0 million (Q1 2026), and -$1.8 million (Q4 2025), per Business Quant data.